LifeStance Health Group, Inc. Diluted Shares Outstanding (Weighted Average)
LifeStance Health Group, Inc. (LFST) reported Diluted Shares Outstanding (Weighted Average) of 387.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 387.30M shares, a 0.15% increase year-over-year.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 395.08M shares, a 1.13% increase year-over-year.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 407.53M shares, a 7.12% increase year-over-year.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 388.89M shares, a 2.24% increase year-over-year.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 391.14M shares, a 3.16% increase from fiscal 2024.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 379.15M shares, a 3.18% increase from fiscal 2023.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 367.46M shares, a 3.43% increase from fiscal 2022.
- LifeStance Health Group, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 355.28M shares, a 108374.21% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 387.30M shares 10-Q · filed 2026-08-06 | 391.18M shares 10-Q · filed 2026-08-06 | 396.64M shares derived: average of 3 quarters · filed 2026-08-06 | 394.70M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 395.08M shares 10-Q · filed 2026-05-07 | 401.31M shares derived: average of 2 quarters · filed 2026-05-07 | 397.17M shares derived: average of 3 quarters · filed 2026-05-07 | 394.56M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 407.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 398.21M shares derived: average of 2 quarters · filed 2026-02-25 | 394.39M shares derived: average of 3 quarters · filed 2026-08-06 | 391.14M shares 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | 388.89M shares 10-Q · filed 2025-11-06 | 387.81M shares derived: average of 2 quarters · filed 2026-08-06 | 385.67M shares 10-Q · filed 2025-11-06 | 386.69M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 386.73M shares 10-Q · filed 2026-08-06 | 385.01M shares 10-Q · filed 2026-08-06 | 385.95M shares derived: average of 3 quarters · filed 2026-08-06 | 384.55M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 390.67M shares 10-Q · filed 2026-05-07 | 385.56M shares derived: average of 2 quarters · filed 2026-05-07 | 383.82M shares derived: average of 3 quarters · filed 2026-05-07 | 382.73M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 380.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 380.40M shares derived: average of 2 quarters · filed 2026-02-25 | 380.08M shares derived: average of 3 quarters · filed 2026-02-25 | 379.15M shares 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | 380.36M shares 10-Q · filed 2025-11-06 | 379.89M shares derived: average of 2 quarters · filed 2025-11-06 | 378.71M shares 10-Q · filed 2025-11-06 | 377.32M shares derived: average of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | 379.43M shares 10-Q · filed 2025-08-07 | 377.88M shares 10-Q · filed 2025-08-07 | 376.31M shares derived: average of 3 quarters · filed 2026-02-25 | 375.35M shares derived: average of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | 376.33M shares 10-Q · filed 2025-05-07 | 374.75M shares derived: average of 2 quarters · filed 2026-02-25 | 373.99M shares derived: average of 3 quarters · filed 2026-02-25 | 371.28M shares derived: average of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | 373.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 372.82M shares derived: average of 2 quarters · filed 2026-02-25 | 369.60M shares derived: average of 3 quarters · filed 2026-02-25 | 367.46M shares 10-K · filed 2026-02-25 | 367.46K shares 10-K · filed 2024-02-28 | |||
| 2023-09-30 | 372.48M shares 10-Q · filed 2024-11-07 | 372.48K shares 10-Q · filed 2023-11-08 | 367.82M shares derived: average of 2 quarters · filed 2024-11-07 | 365.56M shares 10-Q · filed 2024-11-07 | 365.56K shares 10-Q · filed 2023-11-08 | 629.15M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | 363.16M shares 10-Q · filed 2024-08-08 | 363.16K shares 10-Q · filed 2023-08-09 | 362.04M shares 10-Q · filed 2024-08-08 | 362.04K shares 10-Q · filed 2023-08-09 | 714.70M shares derived: average of 3 quarters · filed 2025-02-27 | 536.12M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | 360.90M shares 10-Q · filed 2024-05-09 | 360.90K shares 10-Q · filed 2023-05-10 | 890.48M shares derived: average of 2 quarters · filed 2025-02-27 | 593.77M shares derived: average of 3 quarters · filed 2025-02-27 | 445.42M shares derived: average of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | 1.42B shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 710.20M shares derived: average of 2 quarters · filed 2025-02-27 | 473.59M shares derived: average of 3 quarters · filed 2025-02-27 | 355.28M shares 10-K · filed 2025-02-27 | 355.28K shares 10-K · filed 2024-02-28 | |||
| 2022-09-30 | 357.52K shares 10-Q · filed 2023-11-08 | 355.62K shares derived: average of 2 quarters · filed 2023-11-08 | 354.06K shares 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | 353.73K shares 10-Q · filed 2023-08-09 | 352.30K shares 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | 350.85K shares 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 327.52K shares 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |